173 related articles for article (PubMed ID: 38526639)
1. Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons.
Okafor CN; Eaton L; Watson R
AIDS Behav; 2024 Jun; 28(6):2166-2174. PubMed ID: 38526639
[TBL] [Abstract][Full Text] [Related]
2. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
3. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
[TBL] [Abstract][Full Text] [Related]
4. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
5. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
[TBL] [Abstract][Full Text] [Related]
6. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
[TBL] [Abstract][Full Text] [Related]
7. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.
Campbell CK; Kielhold K; Reynolds HE; Vincent W; Siconolfi DE; Ramos SD; Ogunbajo A; Kegeles SM; Storholm ED
Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791816
[TBL] [Abstract][Full Text] [Related]
8. Awareness of and willingness to use PrEP among Black and Latinx adolescents residing in higher prevalence areas in the United States.
Taggart T; Liang Y; Pina P; Albritton T
PLoS One; 2020; 15(7):e0234821. PubMed ID: 32628674
[TBL] [Abstract][Full Text] [Related]
9. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
[TBL] [Abstract][Full Text] [Related]
10. Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.
Maloney KM; Le Guillou A; Driggers RA; Sarkar S; Anderson EJ; Malik AA; Jenness SM
J Infect Dis; 2021 Jan; 223(1):72-82. PubMed ID: 32882043
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa.
Ogunbajo A; Tsai AC; Kanki PJ; Mayer KH
AIDS Behav; 2022 Jul; 26(7):2363-2375. PubMed ID: 35061117
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
Wood S; Gross R; Shea JA; Bauermeister JA; Franklin J; Petsis D; Swyryn M; Lalley-Chareczko L; Koenig HC; Dowshen N
AIDS Behav; 2019 Oct; 23(10):2719-2729. PubMed ID: 30993479
[TBL] [Abstract][Full Text] [Related]
13. Reactions and Receptivity to Framing HIV Prevention Message Concepts About Pre-Exposure Prophylaxis for Black and Latino Men Who Have Sex with Men in Three Urban US Cities.
Mimiaga MJ; Closson EF; Battle S; Herbst JH; Denson D; Pitts N; Holman J; Landers S; Mansergh G
AIDS Patient Care STDS; 2016 Oct; 30(10):484-489. PubMed ID: 27749110
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
[TBL] [Abstract][Full Text] [Related]
15. Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men.
Patel RR; Crane JS; López J; Chan PA; Liu AY; Tooba R; James AS
PLoS One; 2018; 13(12):e0209484. PubMed ID: 30592756
[TBL] [Abstract][Full Text] [Related]
16. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
17. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
[TBL] [Abstract][Full Text] [Related]
18. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
19. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
[TBL] [Abstract][Full Text] [Related]
20. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
